药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
1-Phenylcyclohexylamine
Lumateperone
The serum concentration of Lumateperone can be increased when it is combined with Rucaparib.
1-Phenylcyclohexylamine
Darolutamide
The serum concentration of Darolutamide can be increased when it is combined with Rucaparib.
1-Phenylcyclohexylamine
Cenobamate
The serum concentration of Cenobamate can be decreased when it is combined with Rucaparib.
1-Phenylcyclohexylamine
Voxelotor
The serum concentration of Voxelotor can be increased when it is combined with Rucaparib.
1-Phenylcyclohexylamine
Givosiran
The serum concentration of Rucaparib can be increased when it is combined with Givosiran.
1-Phenylcyclohexylamine
Lefamulin
Rucaparib may decrease the excretion rate of Lefamulin which could result in a higher serum level.
1-Phenylcyclohexylamine
Acetyldigoxin
Rucaparib may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.
1-Phenylcyclohexylamine
Metildigoxin
Rucaparib may decrease the excretion rate of Metildigoxin which could result in a higher serum level.
1-Phenylcyclohexylamine
Emapalumab
The metabolism of Rucaparib can be increased when combined with Emapalumab.
1-Phenylcyclohexylamine
Siltuximab
The metabolism of Rucaparib can be increased when combined with Siltuximab.
1-Phenylcyclohexylamine
Secukinumab
The metabolism of Rucaparib can be increased when combined with Secukinumab.
1-Phenylcyclohexylamine
Certolizumab pegol
The metabolism of Rucaparib can be increased when combined with Certolizumab pegol.
1-Phenylcyclohexylamine
Golimumab
The metabolism of Rucaparib can be increased when combined with Golimumab.
1-Phenylcyclohexylamine
Rilonacept
The metabolism of Rucaparib can be increased when combined with Rilonacept.
1-Phenylcyclohexylamine
Tocilizumab
The metabolism of Rucaparib can be increased when combined with Tocilizumab.
1-Phenylcyclohexylamine
Canakinumab
The metabolism of Rucaparib can be increased when combined with Canakinumab.
1-Phenylcyclohexylamine
Afelimomab
The metabolism of Rucaparib can be increased when combined with Afelimomab.
1-Phenylcyclohexylamine
Choline salicylate
The risk or severity of adverse effects can be increased when Rucaparib is combined with Choline salicylate.
1-Phenylcyclohexylamine
Nafamostat
The risk or severity of adverse effects can be increased when Rucaparib is combined with Nafamostat.
1-Phenylcyclohexylamine
Fluindione
The metabolism of Fluindione can be decreased when combined with Rucaparib.